| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_119d03d40f99e0ca07888583f0f483c0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-765 |
| filingDate |
1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0eaadeddd664e0155f04dc6138005b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc87015333a7475f799d11068f9ae93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61af005f75675678b61215cc2bd34264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2970d32c769b238f3d8ec3f9f7519a4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda47f8aa38fbe518375d3ff4fccd3de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4a647eaec921e3361885a376f961aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac763eb57ba8643315bee40994f9ef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bfe485108468357c95b666adac5801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49f5dd765687a5ba2875e88417330c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb016fcbc4fbf7bde393633218ac984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c9704716766d1f1c2bb732ef20e2a4 |
| publicationDate |
2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1099708-A1 |
| titleOfInvention |
Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| abstract |
Human serum albumin obtained by gene manipulationntechniques can be purified by a combination of specified stepsnin which a culture supernatant obtained from a human serumnalbumin-producing host is subjected to ultrafiltration, heatntreatment, acid treatment and another ultrafiltration, followednby subsequent treatments with a cation exchanger, a hydrophobicnchromatography carrier and an anion exchanger, and by salting-outnto thereby obtain a pure form of human serum albumin whichncontains substantially no proteinous and polysaccharidencontaminants, which is formulated into a pharmaceuticalnpreparation. This process makes it possible to effecientlynpurify recombinant human serum albumin and to providensubstantially pure human serum albumin which does not containnproducer host-related substances and other contaminants and isnsufficiently free from coloration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1273592-A3 |
| priorityDate |
1992-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |